Background: Glomerular filtration rate (GFR) and urinary albumin excretion (UAE) are markers of kidney function that are known to be heritable. Many endocrine conditions have strong familial components. We tested for association between the Affymetrix GeneChip Human Mapping 100K single nucleotide polymorphism (SNP) set and measures of kidney function and endocrine traits.
Conclusion:
Kidney function traits and TSH are associated with SNPs on the Affymetrix GeneChip Human Mapping 100K SNP set. These data will serve as a valuable resource for replication as more SNPs associated with kidney function and endocrine traits are identified.
Background
Kidney disease affects 19 million adults in the United States [1] . Chronic kidney disease (CKD) is associated with cardiovascular disease [2] [3] [4] , stroke [5] , peripheral arterial disease [5, 6] , and all-cause mortality [7, 8] . CVD risk factors are associated with the development of kidney disease [9] , and the prevalence of traditional and novel CVD risk factors is elevated among those with kidney disease [7, 10] . Urinary albumin excretion (UAE) is an early marker of kidney function that predicts CKD progression [11] [12] [13] [14] . While glomerular filtration rate (GFR) and UAE are both measurements for kidney function, they represent different phenotypes and identify different subsets of at-risk individuals [15] .
Genetic factors play a role in the progression of renal disease. Familial aggregation of end-stage renal disease has been identified [16] . Linkage analyses of kidney function have been conducted [17] [18] [19] [20] [21] , and novel loci have been mapped to chromosomes 1 [18] , 2 [21, 22] , 3 [17] , 7 [22] , 10 [19,20,22] , and 18 [22] . In the Framingham Heart Study, we have shown that kidney function is heritable [23] , suggesting a role for genetic mechanisms in its etiology. Results of the linkage study from the Framingham Heart Study suggested linkage between kidney disease and a locus on chromosome 4 with a LOD score of 2.2 [23] . Familial clustering of UAE has been observed in siblings of subjects with diabetes [24] , and UAE has been shown to be heritable among the offspring of diabetic subjects [25] . Genome-wide linkage analyses have mapped novel loci to chromosomes 12 [26] and 19 [26] among families enriched for hypertension. Among families with more severe forms of nephropathy, suggestive evidence for linkage has been found on chromosome 10p [27] and 9q31-32 [28] . In the Framingham Heart Study, we observed a LOD score of 2.2 for UAE on chromosome 8 [29] .
Thyroid disease, including Hashimoto's thyroiditis and Graves' disease, has a known familial component [30] , and the same genes may underlie both conditions [31] . Measures of thyroid function have been shown to be heritable [32] [33] [34] , and linkage has been reported to chromosome 18 for autoimmune thyroid disease in at least 2 studies [35, 36] .
As part of the Framingham Heart Study 100K Project, we sought to test the relation of multiple kidney and endocrine traits to 70,987 SNPs. In this manuscript, we focus the results of association studies for GFR, UAE, cysC, and thyroid stimulating hormone (TSH), a sensitive measure of thyroid function.
Methods
Overall, 1345 participants were genotyped for the Affymetrix GeneChip Human Mapping 100K SNP set. For this manuscript, we focused on GFR from examination 7, UAE from examination 6, serum cysC from examination 7, and mean TSH from examinations 3 and 4. Phenotypes were available in 1010 participants for GFR at exam cycle 7, 822 participants for UAE at exam cycle 6, 981 participants for cysC at exam cycle 7, and 810 participants for mean TSH at exam cycles 3 and 4. Details about the selection process and genotyping are provided in the Overview [37] . Age-sex-and multivariable-adjusted residuals were generated; we present here only the results for multivariable-adjusted traits (all available results can be found in the website http://www.ncbi.nlm.nih.gov/projects/gap/cgibin/study.cgi?id=phs000007). We evaluated associations with 70,987 SNPs on autosomes with minor allele frequencies of at least 0.10, HWE p-value ≥ 0.001, and genotypic call rates of at least 80%.
Phenotype assessment
Serum creatinine was measured using the modified Jaffe method at exams 2 (1978-1981) , 5 (1991-1995) , 6 (1995-1998) , and 7 (1998-2001) , and glomerular filtration rate (GFR) was estimated using the simplified Modification of Diet in Renal Disease Study equation [38, 39] . CKD was defined based on the National Kidney Foundation Kidney Disease Outcome Quality Initiative working group, and modified slightly as previously described [9] . Urinary albumin concentration (UAE) was measured by immuno-turbidmetry (Tina-quant Albumin assay; Roche Diagnostics, Indianapolis, IN) during the sixth examination cycle (1995) (1996) (1997) (1998) . Urinary albumin was indexed to urinary creatinine (as the urine albumin/creatinine ratio, UACR) in order to account for differences in urine concentration. UACR is a validated and reliable single-sample measure of urinary albumin excretion and is highly correlated with albumin excretion rates assessed by 24-h urine collection [40, 41] . Cystatin-C (cysC) was measured using particle enhanced immunonephelometry (Dade Behring BN 100 nephelometer; Dade Behring -Cystatin C reagent) with an inter-assay and intra-assay coefficient of variation of 3.3 and 2.4%, respectively. We have previously published correlates of CKD in the Framingham Heart Study, including hypertension, diabetes, smoking, obesity, and low HDL cholesterol [9, 42] . TSH was measured using a chemoluminescence assay (London Diagnostics, Eden Prairie, Minn) with a lower limit of detection of 0.01 mU/L. Luteinizing hormone (LH), follicle stimulating hormone (FSH), and dehydroepiandrosterone sulfate (DHEAS) were measured as previously described [43, 44] . Briefly, DHEAS concentrations were measured on serum samples via radioimmunoassay (Diagnostic Products Corp, CA). Calcium and phosphorous were measured at the second examination cycle using a standard colorimetric method (Roche Diagnostics, Alameda, CA), and uric acid was measured at the second examination cycle using an autoanalyzer with a phosphotungstic acid reagent.
Genotyping
Genotyping was performed using the 100K Affymetrix GeneChip. Please see the Overview [37] for details.
Statistical methods
Phenotypes used for the analysis were created by generating normalized residuals. We generated both age-sex adjusted and multivariable adjusted residuals for each trait. Table 1 shows the covariates included in the multivariable adjustment; all data in this manuscript represents the multivariable-adjusted traits. All association analyses were performed using the generalized estimating equations or family based association tests; details are provided in the Overview [37] . Methods to verify family structure, generate identity-by-descent for these 1345 participants with genotype information as well as the markers used for linkage analysis, is detailed in the Overview [37] . To assess the clustering of significance between each SNP and phenotypes that were repeatedly measured in several examination cycles (see the third table in this article), we generated the geometric mean of p-values for SNPs that fit the following criteria: at least 4 out of 6 p-values of <0.01 in GEE or FBAT analyses for 6 GFR traits (change in serum creatinine from exam 2 to 7; GFR at exam 2; GFR at exam 5; GFR at exam 6; GFR at exam 7; mean GFR exams 2, 5, 6, 7); one out of two UACR traits (UACR; UACR in a sample enriched for hypertension); three out of three of TSH traits (TSH at exam 3; TSH at exam 4; mean TSH at exams 3 and 4). Among the GFR traits, Pearson correlation coefficients ranged from 0.18 (p < 0.001) between GFR at exam 2 and exam 7, to 0.77 (p < 0.001) for the mean of GFR at exams 2, 5, 6, and 7 and GFR at exam 7. Linkage analysis was performed using the variance components methods on a subset of 100K markers and Marshfield short-tandem repeats; please see the Overview [37] for more details. Partial R 2 , the adjusted percentage of the phenotype variation explained by the genotype variation, was estimated by subtracting the adjusted R 2 value for a model that excludes the genotype from the R 2 value for a model that includes the genotype.
Results
A description of all traits and phenotypes, including relevant examination cycles and multivariable-adjustments, is presented in Table 1 . The median eGFR among individuals with CKD in our sample is 53.7 ml/min/1.73 m 2 . Table 2a presents the top 25 SNPs with the lowest p-values obtained via GEE for GFR, cysC, UAE, and mean TSH; additional results can be found on the National Center for Biotechnology Information website http:// www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/ study.cgi?id=phs000007. The top SNP associated with GFR, cysC, and UAE were rs2829235 (p-value 1.6*10 -05 ), rs1158167 (p-value 8.5*10 -09 ) near the cysC precursor gene family (CST3, CST4, CST9), and rs1712790 (p-value 1.9*10 -06 ), respectively (Table 2a ). The top SNP to be associated with mean TSH was rs6977660 (p-value 3.7*10 -06 ). Three SNPs were not shown on Table 2a due to the linkage disequilibrium (LD) (r 2 > 0.8) with the other top SNPs. These three SNPs were significantly associated with UAE at exam 6: rs9305355 (p-value 2.1*10 -5 ) in LD with rs9305354, rs725304 (p-value 2.5*10 -5 ) in LD with rs723464, and rs725307 (p-value 3.2 *10 -5 ) in LD with rs723464. Table 2b presents the top SNPs based on the FBAT procedure. One SNP, rs10511594 (p = 9.0*10 -5 ) was in LD (r 2 > 0.8) with rs7865184 (p = 4.0*10 -5 ) for mean TSH. Table 2c presents all traits examined with LOD scores of at least 2.5. One locus on chromosome 1 (nearest marker on the 100K GeneChip, rs10489578) was linked to GFR with a LOD score of 3.08. We observed a LOD score of 4.28 for uric acid to chromosome 2 (nearest marker rs10495487), a location we have previously identified using Marshfield linkage analysis to uric acid [45] . Table 3 presents the top SNPs for our multiple phenotype analysis for GFR, UAE, and TSH with a total of 24 SNPs showing consistently significant associations with multiple related phenotypes. Tables 4a and 4b present results looking at replication of genes that have been associated with kidney traits in the published literature. Four SNPs in or near the CST3 gene were highly correlated with cysC levels (p-value 8.5*10 -09 to 0.007). All four SNPs have minor allele frequencies greater than 10% and none were in linkage disequilibrium (defined by R 2 > 0.8) as shown on Table 4 . The proportion of the cysC variation that can be explained by these SNPs is shown in Table 4 . rs1158167 accounts for 2.5% of the cysC variation. We found nominal significance between a SNP near the APOE gene and CKD (p = 0.04).
Additional findings
We also identified several other plausible candidate genes that appear in our list of top 500 SNPs for each trait (see http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/ study.cgi?id=phs000007). For GFR, we identified LRP1B (GEE p-value = 0.0006, rs1049688), ADRBK2 (GEE pvalue = 0.002, rs1048312), APOB (GEE p-value = 0.003, rs1048312), several genes in the chromosome 17 cytokine gene cluster including CCL3, CCL4, and CCL18 (GEE pvalue 0.004, rs1818816), SCARB1 (GEE p-value = 0.004, rs1902569), NFKB1 (FBAT p-value = 0.001, rs230489), TGFB1 (FBAT p-value = 0.003, rs2072239), and PPARG (FBAT p-value = 0.005, rs709157). For UAE, we also identified a SNP in the LRP1B gene (GEE p-value = 0.004, rs1049687). For cysC, we identified SNPs in the LRP1B gene (GEE p-value = 0.001, rs1463615), ANGPT1 (GEE pvalue = 0.005, rs4354281), NFKB1 (FBAT p-value = 0.004, rs2991716), and PPARG (FBAT p-value = 0.004, rs1051041). For mean TSH, we identified SNPs in ADRBK2 (GEE p-value = 0.002, rs3888397), TRHDE (GEE p-value = 0.002, rs2044305) and DIO2 (GEE p-value = 0.003, rs54566), the SCD4 gene (rs10516679 GEE pvalue = 0.0007 FBAT p-value = 0.02), VLDLR (FBAT pvalue = 0.002, rs4084415) and APOBEC2P (FBAT p-value = 0.005, rs722442).
Discussion
In our analysis of kidney-related traits, we have found strong evidence for association between multiple kidneyrelated traits and TSH with SNPs on the Affymetrix 100K GeneChip. We found strong evidence for association between cysC levels and 4 SNPs in or near the CST3 gene. For UAE, we observed strong association with ADAM23, a gene involved in the metalloproteinase family, which may be involved in the pathophysiology of glomerulosclerosis [46] , and PCDH9, a gene that is a member of the cadherin superfamily. For TSH, we observed significant association with the HSPA4L gene with a mean p-value for all three TSH measurements, a gene that is part of the heat shock protein family, which may be involved in the pathophysiology of thyroid disease [47] . We also observed association with the SCD4 gene, a gene involved in the conversion of saturated to monounsaturated fatty acids; TSH is an important correlate of lipid levels [48].
In our linkage results, we observed a region we have previously noted for uric acid [45], albeit with a significantly higher LOD score. We identified a LOD score of 2.78 on chromosome 3, approximately 18 Mb away from a region previously noted in association with kidney function in hypertensive individuals [17] , a region that lies within our 1.5 support LOD interval. We also report novel loci for GFR and TSH.
We show significant association between cysC levels and the CST3 gene, an observation that has been previously noted [49] . Our top SNP reaches genome-wide significance, and may represent a true finding. In our candidate gene approach, we found nominal significance for a SNP near the APOE gene, a gene that has been associated with CKD [50] . Unfortunately, poor coverage of the APOE gene by the Affymetrix 100K Genechip precluded a more indepth test of association with SNPs in the APOE gene and CKD.
Strengths of our study lie in our assessment of multiple measures of kidney function and endocrine traits in a sample unselected for these traits, thus reducing bias. We 
Conclusion
Kidney function traits and TSH are associated with SNPs on the Affymetrix 100K SNP GeneChip. Replication of association between these traits and SNPs requires followup in independent samples. These data will serve as a valuable resource for replication as more SNPs associated with kidney function and endocrine traits are identified.
Abbreviations CKD = chronic kidney disease; cysC = cystatin-C; DHEAS = dehydroepiandrosterone sulfate; FBAT = family-based association tests; FSH = follicle stimulating hormone; GEE = generalized estimating equations; GFR = glomerular filtration rate; LD = linkage disequilibrium; LH = luteinizing hormone; MDRD = Modification of Diet in Renal Disease; SNP = single nucleotide polymorphism; TSH = thyroid stimulating hormone; UAE = urinary albumin excretion.
